Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Symbio Pharmaceuticals (4582 JP)
Watchlist
43
Analysis
Health Care
•
Japan
Symbio Pharmaceuticals Limited develops and commercializes prescription drugs n oncology, hematology and auto-immune disease for Japan and other Asia Pacific markets.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Symbio Pharmaceuticals
•
07 Feb 2025 10:00
•
Issuer-paid
Symbio Pharmaceuticals (4582 JP): Full-year FY12/24 flash update
Sales decreased by 56.1% YoY to JPY2.5bn, with a gross profit of JPY1.9bn and a gross margin of 76.4%. Operating loss increased to JPY3.9bn in...
Shared Research
Follow
203 Views
Share
bullish
•
Symbio Pharmaceuticals
•
31 Oct 2024 20:00
•
Issuer-paid
Symbio Pharmaceuticals (4582 JP): Q3 FY12/24 flash update
Sales decreased by 57.1% YoY to JPY1.9bn, with operating, recurring, and net losses each at JPY2.8bn. SG&A expenses increased by 12.7% YoY to...
Shared Research
Follow
242 Views
Share
bullish
•
Symbio Pharmaceuticals
•
02 Aug 2024 08:00
•
Issuer-paid
Symbio Pharmaceuticals (4582 JP): 1H FY12/24 flash update
Sales decreased by 59.6% YoY to JPY1.3bn, with a gross profit of JPY996mn and a gross profit margin of 77.6%. Operating loss was JPY1.7bn,...
Shared Research
Follow
207 Views
Share
bullish
•
Symbio Pharmaceuticals
•
29 Apr 2022 23:25
•
Issuer-paid
SymBio Pharmaceuticals - Termination of coverage
Edison Investment Research is terminating coverage on Brooge Energy (BROG), Tyman (TYMN), SymBio Pharmaceuticals (4582), Aspire Global (0EAZ),...
Edison Investment Research
Follow
128 Views
Share
bearish
•
Quantitative Analysis
•
21 Jun 2021 17:43
Asia Shorts: Geely, Ganfeng, Pharmaron, Evergrande, Fujitsu, Canon, Renesas, Toshiba, LGD, Doosan
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
345 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x